Evidence map›Paper›PMID 34602490›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.

Luwen Wang, Mengyu Liu, Ju Gao, Amber M Smith, Hisashi Fujioka, Jingjing Liang, George Perry, Xinglong Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Luwen WangDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, NE, USA.
Mengyu LiuDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Ju GaoDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, NE, USA.
Amber M SmithDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Hisashi FujiokaElectron Microscopy Core Facility, Case Western Reserve University, Cleveland, OH, USA.
Jingjing LiangDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
George PerryCollege of Sciences, University of Texas at San Antonio, San Antonio, TX, USA.
Xinglong WangDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, NE, USA.
Case Western Reserve University · USUniversity of Nebraska Medical Center · USThe University of Texas at San Antonio · US

Funding

FAM222A and amyloid plaque deposition in Alzheimer's DiseaseRF1AG066578 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MIYAGI, MASARU, WANG, XINGLONG · 2020 to 2020
$2.8M
Mitochondrial modulation of neuroinflammation in AD and related tauopathiesRF1AG065342 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, XINGLONG · 2020 to 2020
$2.2M
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALSR01NS097679 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, XINGLONG · 2017 to 2021
$2.0M
Mitochondrial TDP-43 in Alzheimer's DiseaseRF1AG056320 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, XINGLONG · 2019 to 2019
$2.0M
NIA NIH HHS RF1 AG056320NIA NIH HHS RF1 AG065342NIA NIH HHS RF1 AG066578NINDS NIH HHS R01 NS097679
6 · The paper itself

Abstract

backgroundAbnormalities of mitochondrial fission and fusion, dynamic processes known to be essential for various aspects of mitochondrial function, have repeatedly been reported to be altered in Alzheimer's disease (AD). Neurofibrillary tangles are known as a hallmark feature of AD and are commonly considered a likely cause of neurodegeneration in this devastating disease.

objectiveTo understand the pathological role of mitochondrial dynamics in the context of tauopathy.

methodsThe widely used P301S transgenic mice of tauopathy (P301S mice) were crossed with transgenic TMFN mice with the forced expression of Mfn2 specifically in neurons to obtain double transgenic P301S/TMFN mice. Brain tissues from 11-month-old non-transgenic (NTG), TMFN, P301S, and P301S/TMFN mice were analyzed by electron microscopy, confocal microscopy, immunoblot, histological staining, and immunostaining for mitochondria, tau pathology, and tau pathology-induced neurodegeneration and gliosis. The cognitive function was assessed by the Barnes maze.

resultsP301S mice exhibited mitochondrial fragmentation and a consistent decrease in Mfn2 compared to age-matched NTG mice. When P301S mice were crossed with TMFN mice (P301S/TMFN mice), neuronal loss, as well as mitochondria fragmentation were significantly attenuated. Greatly alleviated tau hyperphosphorylation, filamentous aggregates, and thioflavin-S positive tangles were also noted in P301S/TMFN mice. Furthermore, P301S/TMFN mice showed marked suppression of neuroinflammation and improved cognitive performance in contrast to P301S mice.

conclusionThese in vivo findings suggest that promoted mitochondrial fusion suppresses toxic tau accumulation and associated neurodegeneration, which may protect against the progression of AD and related tauopathies.

Indexed as

AnimalsCognitive DysfunctionDisease Models, AnimalGliosisHumansImmunohistochemistryMiceMice, TransgenicMicroscopy, ElectronMitochondrial DynamicsNeurodegenerative DiseasesNeurofibrillary TanglesNeuronsTauopathiesCognitive declineMfn2mitochondrial dynamicsmitochondrial fusionneurodegenerationneuroinflammationtau pathology

Identifiers

PMID34602490
PMCPMC9354499
OpenAlexW3204775201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.